Our analyses suggest that the deregulation of FOXM1 and AURKB pathways may contribute to the progression from hormone-dependent to hormone-independent growth of breast cancer since our results show that the activity of both pathways is higher in ER-negative, PGR-negative breast cancer. This evidence concerns the gene AURKB and breast cancer.